|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 29 July 2008
doi: 10.1242/jcs.031922
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |

1 Leibniz-Institute of Age Research, Fritz-Lipman-Institute, Beutenbergstr. 11, 07745 Jena, Germany
2 Institute of Computer Science, Friedrich-Schiller-University, 07743 Jena, Germany
3 The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA
4 German Cancer Research Center, Im Neuenheimer Feld 242, 69120 Heidelberg, Germany
Author for correspondence (e-mail: phemmer{at}fli-leibniz.de)
Accepted 27 May 2008
PML nuclear bodies (NBs) are involved in the regulation of key nuclear pathways but their biochemical function in nuclear metabolism is unknown. In this study PML NB assembly dynamics were assessed by live cell imaging and mathematic modeling of its major component parts. We show that all six nuclear PML isoforms exhibit individual exchange rates at NBs and identify PML V as a scaffold subunit. SP100 exchanges at least five times faster at NBs than PML proteins. Turnover dynamics of PML and SP100 at NBs is modulated by SUMOylation. Exchange is not temperature-dependent but depletion of cellular ATP levels induces protein immobilization at NBs. The PML-RAR
oncogene exhibits a strong NB retention effect on wild-type PML proteins. HIPK2 requires an active kinase for PML NB targeting and elevated levels of PML IV increase its residence time. DAXX and BLM turn over rapidly and completely at PML NBs within seconds. These findings provide a kinetics model for factor exchange at PML NBs and highlight potential mechanisms to regulate intranuclear trafficking of specific factors at these domains.
Key words: Nuclear body, Promyelocytic leukemia, SP100, SUMO, RAR
, Assembly, Kinetics modeling, FRAP, FCS
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
Related articles in JCS:
This article has been cited by other articles:
![]() |
M. Lang, T. Jegou, I. Chung, K. Richter, S. Munch, A. Udvarhelyi, C. Cremer, P. Hemmerich, J. Engelhardt, S. W. Hell, et al. Three-dimensional organization of promyelocytic leukemia nuclear bodies J. Cell Sci., February 1, 2010; 123(3): 392 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Percherancier, D. Germain-Desprez, F. Galisson, X. H. Mascle, L. Dianoux, P. Estephan, M. K. Chelbi-Alix, and M. Aubry Role of SUMO in RNF4-mediated Promyelocytic Leukemia Protein (PML) Degradation: Sumoylation of pml and phospho-switch control of its sumo binding domain dissected in living cells J. Biol. Chem., June 12, 2009; 284(24): 16595 - 16608. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jegou, I. Chung, G. Heuvelman, M. Wachsmuth, S. M. Gorisch, K. M. Greulich-Bode, P. Boukamp, P. Lichter, and K. Rippe Dynamics of Telomeres and Promyelocytic Leukemia Nuclear Bodies in a Telomerase-negative Human Cell Line Mol. Biol. Cell, April 1, 2009; 20(7): 2070 - 2082. [Abstract] [Full Text] [PDF] |
||||